J&J to spin off orthopedics business, sees 2026 sales growth of over 5%
PositiveFinancial Markets

Johnson & Johnson has announced plans to spin off its orthopedics business, projecting a sales growth of over 5% by 2026. This strategic move is significant as it allows J&J to focus on its core operations while potentially unlocking greater value for shareholders. The separation could lead to enhanced innovation and efficiency in both the orthopedics sector and J&J's remaining business units, making it a noteworthy development in the healthcare industry.
— Curated by the World Pulse Now AI Editorial System